Prokocimer Philippe
Chief Medical Officer at Trius Therapeutics Inc
- Sold, on record
- $244k
- Dollars the filings state
- Form 4 sales
- 6
- Latest Jul 1, 2013
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Trius Therapeutics IncChief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Trius Therapeutics IncPlan not statedOct 27, 2011 2011
Sold 1,687 shares at $7.45 ($13k)
Prokocimer Philippe, Chief Medical Officer
Sold 2.1% of holdings ($604k position)79,383 shares leftFirst sale on recordFiling
- 2 Form 4 sale Trius Therapeutics IncPlan not statedOct 31, 2011 +4 days
Sold 1,687 shares at $7.45 ($13k)
Prokocimer Philippe, Chief Medical Officer
Sold 2.1% of holdings ($604k position)79,383 shares leftFiling
- 3 Form 4 sale Trius Therapeutics IncPlan not statedMay 13, 2013 +560 days
Sold 12,000 shares at $7.65 ($92k)
Prokocimer Philippe, Chief Medical Officer
Sold 12.2% of holdings ($750k position)86,022 shares leftFiling
- 4 Form 4 sale Trius Therapeutics IncUnusualMay 24, 2013 +11 days
Sold 12,000 shares at $7.93 ($95k)
Prokocimer Philippe, Chief Medical Officer
Sold 12.2% of holdings ($777k position)86,022 shares left7.1x usual sizeFiling
- 5 Form 4 sale Trius Therapeutics IncPlan not statedJun 3, 2013 +10 days
Sold 2,000 shares at $7.75 ($16k)
Prokocimer Philippe, Chief Medical Officer
Sold 2.3% of holdings ($667k position)84,022 shares left0.3x usual sizeFiling
- 6 Form 4 sale Trius Therapeutics IncPlan not statedJul 1, 2013 +28 days
Sold 2,000 shares at $8.14 ($16k)
Prokocimer Philippe, Chief Medical Officer
Sold 2.4% of holdings ($684k position)82,022 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2013 | Jul 1, 2013 | Trius Therapeutics Inc | Chief Medical Officer | Form 4 sale | 2,000 | $16k | 2.4% | Plan not stated | SEC |
| Jun 3, 2013 | Jun 3, 2013 | Trius Therapeutics Inc | Chief Medical Officer | Form 4 sale | 2,000 | $16k | 2.3% | Plan not stated | SEC |
| May 24, 2013 | May 28, 2013 | Trius Therapeutics Inc | Chief Medical Officer | Form 4 sale | 12,000 | $95k | 12.2% | Unusual | SEC |
| May 13, 2013 | May 15, 2013 | Trius Therapeutics Inc | Chief Medical Officer | Form 4 sale | 12,000 | $92k | 12.2% | Plan not stated | SEC |
| Oct 31, 2011 | Nov 2, 2011 | Trius Therapeutics Inc | Chief Medical Officer | Form 4 sale | 1,687 | $13k | 2.1% | Plan not stated | SEC |
| Oct 27, 2011 | Oct 31, 2011 | Trius Therapeutics Inc | Chief Medical Officer | Form 4 sale | 1,687 | $13k | 2.1% | Plan not stated | SEC |